Vol 2, Issue 9, September 24, 2020/previous issue/next issue/UKR

In Short


Almost 5 years after its legislative creation National Research Fund of Ukraїna announced results of the first competitions [1, 2].



Blood plasma obtained from people that successfully overcame COVID-19 and enriched in antibodies against SARS-CoV-2, that was hoped to be useful in treatment of COVID-19, so far has not demonstrated good results in clinical trials in developed countries [3].



Used sources:


1. List of the projects of competition “Science for safety of human and society” that are recommended for realization and funding by National Research Fund of Ukraїna and amount of funding allocated to them (https://nrfu.org.ua/wp-content/uploads/2020/09/konkurs-1_peremozhczi_publikacziya.doc.pdf).



2. List of the projects of competition “Support of research of leading and young scientists” that are recommended for realization and funding by National Research Fund of Ukraїna and amount of funding allocated to them (https://nrfu.org.ua/wp-content/uploads/2020/09/konkurs-2_peremozhczi-publikacziya.pdf).



3. Kai Kupferschmidt, Jon Cohen, In plasma OK, critics see politics, not science, Science 28 Aug 2020, Vol. 369, Issue 6507, pp. 1038-1039 (https://science.sciencemag.org/content/369/6507/1038.long).





naukovinovyny.com